Tobramycin,Benzalkonium Chl. - Zoekresultaten

Australië - Engels - Department of Health (Therapeutic Goods Administration)

tobrex eye ointment

novartis pharmaceuticals australia pty ltd - tobramycin, quantity: 3 mg/g - eye ointment - excipient ingredients: liquid paraffin; white soft paraffin; chlorobutanol hemihydrate - indications as at 02 may 1984 : tobrex is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

tobrex

novartis new zealand ltd - tobramycin 0.3%{relative}; - eye ointment - 0.3 % - active: tobramycin 0.3%{relative} excipient: chlorobutanol liquid paraffin white soft paraffin - tobrex eye ointment is indicated for the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex.

Verenigde Staten - Engels - NLM (National Library of Medicine)

tobradex st- tobramycin / dexamethasone suspension/ drops

eyevance pharmaceuticals, llc - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - tobradex st ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: sta